foxo4-dri peptide senolytic mouse study 2023 2024

foxo4-dri peptide senolytic mouse study 2023 2024 The disordered p53 transactivation domain is the target of FOXO4 and the compound FOXO4-DRI UK | Senolytic Peptide

Name: foxo4-dri peptide senolytic mouse study 2023 2024 The disordered p53 transactivation domain is the target of FOXO4 and the compound FOXO4-DRI UK | Senolytic Peptide
Brand: tmdnewgeneration.cz
SKU: 6717436011
Price: 21.64 USD
Availability: InStock
Rating: 4.7731 (15 reviews)

FOXO4 DRI UK Senolytic Peptide Research Peptides Lab UK FOXO4 DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53 serine 15 phosphorylation Communications Biology Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells eBioMedicine

SKU: 6717436011 · From tmdnewgeneration.cz

4.8

USD21.64 USD70.64

Pay in 4 interest-free payments of $5.41 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Nov 8 - Nov 13

Description

Complementary DNA (cDNA) was made by reverse transcription of RNA (2 g) using Moloney murine leukemia virus reverse transcriptase (Promega, Madison, MI, USA) and labeled with Biotin-16-2-deoxy-uridine-5-triphosphate (Roche Diagnostics, Indianapolis, IN, USA)

Its short peptide structure allows researchers to work with clearly defined molecular compositions, improving experimental reproducibility and analytical accuracy